Alpha 2.0
Login Register
» Articles » PMID: 33364246

Six Recommendations to Build Legitimacy for Translational Research Organizations

Overview
Journal Front Med (Lausanne)
Specialty General Medicine
Date 2020 Dec 28
PMID 33364246
Authors
Christian Rosser
Fritz Sager
Stephen L Leib
Affiliations
Soon will be listed here.
Abstract

Translational research organizations (TROs) face specific challenges to secure resilience and longevity. This perspective article provides the rationale for six hands-on recommendations for the management of legitimacy building in TROs.

References
1.
Polese F, Capunzo M . The determinants of translational medicine success - a managerial contribution. Transl Med UniSa. 2013; 6:29-34. PMC: 3829794. View
2.
Gilliland C, Zuk D, Kocis P, Johnson M, Hay S, Hajduch M . Putting translational science on to a global stage. Nat Rev Drug Discov. 2016; 15(4):217-8. PMC: 5378162. DOI: 10.1038/nrd.2016.33. View
3.
Fudge N, Sadler E, Fisher H, Maher J, Wolfe C, McKevitt C . Optimising Translational Research Opportunities: A Systematic Review and Narrative Synthesis of Basic and Clinician Scientists' Perspectives of Factors Which Enable or Hinder Translational Research. PLoS One. 2016; 11(8):e0160475. PMC: 4973909. DOI: 10.1371/journal.pone.0160475. View
4.
Collins F . Reengineering translational science: the time is right. Sci Transl Med. 2011; 3(90):90cm17. PMC: 5101940. DOI: 10.1126/scitranslmed.3002747. View
5.
Mankoff S, Brander C, Ferrone S, Marincola F . Lost in Translation: Obstacles to Translational Medicine. J Transl Med. 2004; 2(1):14. PMC: 420261. DOI: 10.1186/1479-5876-2-14. View